Thank you for writing to us. One of our executive will reach back to you through your submitted medium. In case there’s an urgency, feel free to connect over WhatsApp for faster response.
Prefer calling? Dial +918265041513 (International callers) or +918265041513 (Indian callers).
Imatib 400mg (Generic Gleevec) Halifax — Imatinib for CML & GIST | Nova Scotia, Canada 2026
Product Details
Imatib 400mg contains Imatinib Mesylate 400mg, a targeted tyrosine kinase inhibitor (TKI) used to treat certain cancers driven by abnormal tyrosine kinase activity. It is commonly prescribed for Philadelphia chromosome-positive Chronic Myeloid Leukemia (CML) and for eligible patients with Gastrointestinal Stromal Tumors (GIST). Depending on clinical circumstances, it may also be used for certain other approved conditions under specialist supervision.
At Unnati Pharmax, we export high-quality generic Imatinib tablets manufactured in WHO-GMP-certified Indian facilities to customers in Halifax, Nova Scotia, Canada, and other international destinations, subject to local import regulations.
Product Specifications
Brand Name
Imatib 400mg
Generic Name
Imatinib Mesylate
Strength
400 mg
Dosage Form
Tablets
Therapeutic Category
Oncology / Hematology
Indications
Chronic Myeloid Leukemia (CML), Gastrointestinal Stromal Tumor (GIST), other approved indications as prescribed
Drug Class
Tyrosine Kinase Inhibitor (TKI)
Route of Administration
Oral
Storage
Store below 25°C in a cool, dry place away from moisture and sunlight
Prescription Required
Yes
Manufacturer
Indian WHO-GMP Certified Manufacturer
Export Availability
Halifax, Nova Scotia, Canada & International Markets
Key Features
Contains Imatinib Mesylate 400mg
Generic alternative to Gleevec®
Used for the treatment of Philadelphia chromosome-positive CML and eligible GIST patients
Oral tablet for convenient daily administration
Manufactured in WHO-GMP-certified facilities
Quality-tested with export-grade packaging
Competitive pricing for international buyers
Available for pharmacies, hospitals, wholesalers, and licensed importers
Secure international shipping from India
Worldwide export support with tracking
Industry Update
Imatinib continues to be a cornerstone targeted therapy for Philadelphia chromosome-positive Chronic Myeloid Leukemia (CML) and remains an important treatment option for selected patients with Gastrointestinal Stromal Tumors (GIST). While newer tyrosine kinase inhibitors have expanded treatment options for patients with resistance or intolerance, imatinib remains widely used because of its well-established long-term efficacy, safety profile, and clinical experience. The increasing availability of quality-assured generic imatinib has also improved access to treatment in many countries, helping reduce costs while maintaining high manufacturing standards. Treatment decisions should always follow current oncology guidelines and be made by a qualified healthcare specialist.
Chat with us
Chat with us
